Abstract. The pathobiochemical mechanism of arte riosclerosis in hyperhomocysteinaemiu has not yet been elucidated. In vitro studies have shown that the cytotoxic properties o f homocysteine can be ascribed to its generation of reactive oxygen species, We studied lipid peroxidation, both in vivo and in vitro, in 10 homozygous cystathionine synthase-deficicnt (GSD) patients and in a control group of 10 healthy subjects of comparable age and sex. The susceptibility of low-density lipoprotein (LDL) from hyperhomocysteinaemic patients to oxidation was determined in vitro by continuously measuring the conjugated diene production induced by incubation with copper ions, Oxidation resistance (expressed as lag time), maximal oxidation rate, and extent o f oxidation (expressed as total diene production) of LDL from CSD patients were not significantly different from those o f LDL from controls. Furthermore, the time needed to reach maximal diene production, i.e. t(max), was similar lor LDL from patients and controls. In addition, the vitamin E concentrations in LDL o f CSD patients and controls were similar. The mean concentration (d::SD) o f plasma thiobarbituric acid reactive sub stances (TBARS), an indicator of in vivo lipid per oxidation, was 2-2 ± 0*7 //mol L 1 in CSD patients, a lower value than that measured in the matched con trols (5*0 ± 2*0 /¿mol L 1). investigation o f in vivo and in vitro parameters o f lipid peroxidation shows that the increased risk of arteriosclerosis in hyperhomo cysteinaemia is unlikely to be due to increased lipid peroxidation.
Introduction
Severe hyperhomocysteinaemia caused by cystathio nine synthase deficiency (CSD) is a rare autosomal recessive inborn error o f the methionine transsulphuration pathway. About 50% o f untreated patients suffer from arteriosclerosis or thrombocmbolisms before 30 years of age [1] , Over tlie. last 10 years it has become evident that mild hyperhomocysteinaemia is also an independent risk factor for vascular disease [2] [3] [4] [5] [6] [7] [8] , and very recently it has been shown to be a risk factor for obstetric complications such as recurrent spontaneous abortion, gross placen tal infarcts and neural-tube defects [9, 10] . Both severe and mild hyperhomocysteinaemia can be effectively treated with simple regimens o f vitamin Bfn folate and bctaine [3, 11] . Mudd at al. [1] were able to demon strate that homocysteine-lowering therapy reduced the vascular risk of patients with severe hyperhomo cysteinaemia due to CSD, The pathobiochemical mechanism o f hyperhomo cysteinaemia has not yet been elucidated. Endothelial damaging effects of homocysteine have been demon strated in vitro and in animal studies (for reviews see [3, 6, 7] ). Cultured endothelial cells are damaged by exposure to high concentrations o f homocysteine, most probably because o f hydrogen peroxide for mation [12] , Furthermore, other thiol-containing amino acids, e.g. cysteine, could induce oxygen radi cal production, leading to low density lipoprotein (LDL) modification [13] . Oxidative modification o f LDL is thought to constitute the link between increased plasma cholesterol concentrations and atherosclerosis [14] [15] [16] . Reactive oxygen species, such as superoxide, hydrogen peroxide and the hydro xyl radical, can be formed by auto-oxidation o f thiol groups [12, 13] . Superoxide and hydrogen peroxide are relatively benign compared to the highly reactive hydroxyl radical. The latter is only generated in the presence o f transition metals such as Fe31 and Cu2* [17] , which is o f interest with regard to the elevated blood levels of copper and other metals in CSD patients [18, 19] . Concentrations are expressed as //mol L~*. B^, 750mg pyridoxinc per day administered orally; fol, 5 mg folate per day administered orally; bet, 6 g betaine per day administered orally; Bi2) 1 mg vitamin B12 per month administered intramuscularly.
In a previous short communication we reported normal concentrations o f malondialdehyde and fluor escent lipid peroxidation products in serum of CSD patients [20] . The disadvantage o f using serum for measuring lipid peroxidation products has been dis cussed previously [21, 22] . In the present study, we investigated indications o f lipid peroxidation in vivo and in vitro in EDTA-plasma of hyperhomocysteinaemic CSD patients. To our knowledge, studies on the in vitro susceptibility to oxidation o f LDL from hyperhomocystenaemic patients have not been performed before.
Materials and methods

Patients
Homozygosity for CSD was suspected in the 10 patients (nine males and one female; mean age ± SD, 30*1 ± 6*8 years) on the basis of typical clinical symptoms such as arteriosclerosis, thrombosis, mental retardation, marfanoid features or ectopia lentis, and was confirmed biochemically by severe hyperhomocysteinaemia and (in most cases) elevated methionine and decreased cysteine concentrations in plasma, and by very low cystathionine synthase activity (<10% o f that in controls) in cultured fibro blasts. At the time o f the present investigation, all patients but one (K61) were on therapy, which included pyridoxine (750 mg daily, administered orally) and in some cases folate (5 mg daily, adminis tered orally), betaine (5 g daily, administered orally) or vitamin B I2 (1 mg per month, administered intra muscularly) (Table 1) . D ue to therapy, two patients (E51 and U58) achieved normal homocysteine levels. N o other vitamins and no antioxidants were pre scribed, and the patients had a normal diet. A control group o f 10 healthy subjects (eight males and two females) of mean age (± SD) 34*9 ± 6*0 years was selected for this study. None of the controls used any vitamins or medication. Antecubital venous blood samples were collected in the fasting state in EDTA-containing vials.
Amino acid analysis
Red cells were separated from the plasma within 30 min and the plasma was stored at -2 0°C until analysis. Total homocysteine was measured in EDTAcontaining plasma as described by Fiskerstrand et ai [23] , with some minor modifications. Methionine concentrations in plasma were measured by ionexchange chromatography on an automatic aminoacid analyser (LKB Alpha-plus, Pharmacia, Woer den, The Netherlands).
LDL isolation and in vitro oxidation
Plasma was separated within 30 min and stored at ~80°C in the presence of 6 g saccharose L {. Lowdensity lipoproteins were isolated by a short-run ultracentrifugation method and were thereafter tested for their susceptibility to in vitro copperinduced LDL oxidation [24] . Briefly, after isolation, the LDL was dialysed for 24 h in the dark at 4°C against phosphate-buffered saline (pH 7-4), contain ing 10 /¿mol L r1 EDTA. The buffer was made oxygenfree by vacuum degassing followed by purging with nitrogen. The LDL-containing sample was filtered through a 0*45/um filter and diluted with dialysis buffer to a final concentration of 0*05 mg LDLprotein mL" 1 and 10/¿mol L 1 EDTA. The oxida tion was initiated by the addition of a freshly prepared solution (15//mol L" 1) of copper chloride (C11CI2). The kinetics of LDL oxidation were determined by monitoring the change in 234 nm diene absorption on a UV-spectrophotometer (Lambda 5, Perkin-Elmer, Norwalk, CT, USA), equipped with a six-position automatic sample changer, at 30°C The change of absorbance at 234 nm vs. time was divided into three consecutive phases, i.e. a lag phase, a propagation phase and a decomposition phase (Fig. 1) . Lag time, maximal rate o f oxidation, total amount of conju gated dienes formed, and the time needed to reach maximal diene production were calculated as described previously [24] , and despite a small increase in the free C11CI2 concentration, identical kinetics of LDL oxida tion were observed [24] ,
In vivo lipid peroxidation
The content o f thiobarbituric acid reactive substances (TBARS), mainly malondialdehyde (MDA), in plasma was measured by recording the fluorescence spectrum of the thiobarbituric acid-MDA complex between 500 and 600 nm on a Shimadzu RFF-500 fluorescence detector (Shimadzu Corporation, Kyoto, Japan), keeping a constant interval o f 14 nm between excitation and emission wavelengths. The fluorescence intensity was measured at 553 nm after subtracting the baseline value (due to the Rayleigh diffusion). This synchronous fluorescence method was found to be free from interfering compounds [25] .
Other methods
Cholesterol and triglyceride concentrations in plasma were determined by enzymatic methods (BoehringerMannheim, Mannheim, Germany). Plasma HDLcholesterol was determined by the polyethyleneglycol 6000 method [26] , LDL-cholesterol in plasma was calculated by subtracting the sum of HDLcholesterol and 0-42 x triglycerides from total plasma cholesterol.
The vitamin E concentrations in LDL were deter mined by high performance liquid chromatography (HPLC) as described previously [27] . LDL fatty acid composition was measured as described previously [27] , and was expressed as a percentage of total fatty n /i 1 7 4 
Statistical analysis
The results are expressed as mean values ±SD * Statistical evaluation of the data was performed using Student's Mest. Pearson correlation coeffi cients were computed to determine correlations between homocysteine concentrations and oxidation parameters. A two-tailed P-value of less than 0*05 was considered to be statistically significant.
Results
of total homocysteine concentrations in plasma, from virtually normal levels up to 244//,m olL~1 ( Table 1) 
Susceptibility to oxidation o f low-density lipoprotein and L D L vitamin E content
The susceptibility to oxidation o f LDL from hyperhomocysteinaemic patients was determined in vitro by continuously measuring the conjugated diene produc tion induced by incubation with copper ( Fig. 1) . Oxidation resistance (expressed as lag time), maximal oxidation rate, and extent o f oxidation (expressed as total diene production) o f LD L from CSD patients were not significantly different from control values ( Table 2 ). In addition, the time taken to reach max imal diene production, t(max), was similar for LDL from patients and controls. N o correlations were observed between plasma homocysteine concentra tions and biochemical LDL oxidizability indexes.
The vitamin E content o f LDL was also deter mined, since vitamin E is quantitatively and qualita tively the most important endogenous antioxidant in LDL, Decreased levels o f vitamin E might be indica tive o f increased in vivo exposure to oxidative stress. However, the vitamin E concentrations of LDL did not differ significantly between controls and CSD patients ( Table 2) . N o significant correlation was observed between the concentration o f vitamin E in LDL and the plasma homocysteine concentration.
Plasma homocysteine and methionine
The homozygous CSD patients exhibited a wide range 
Discussion
The susceptibility to in vitro oxidation of LDL from patients with hyperhomocysteinaemia due to CSD was not increased compared to that of LDL from controls. Furthermore, the LDL vitamin E content was not decreased in these CSD patients, and the plasma TBARS concentration, indicative of in vivo lipid peroxidation, was even lower in the CSD patients than in controls. Even in patients with very high homocysteine concentrations (patients D67, B61 and K61), LDL oxidizability and plasma TBARS concen tration were not increased, and the vitamin E content o f LDL was not decreased. These data are in agree ment with our previous data on malondialdehyde and fluorescent lipid peroxidation products in the serum o f hyperhomocysteinaemic patients [20] , and argue against the view that lipid peroxidation acts as a mediator in the vascular damaging effect o f homo cysteine. Many in vitro studies (for reviews, see [3,6,7]) have described endothelial damaging properties of homocysteine mediated through the production of reactive oxygen species. In virtually all o f these studies, applied very high and non-physiological con centrations o f 1 to 10 mM homocysteine, i.e. the reduced form. This is extremely unphysiological because almost all homocysteine in the blood is present in its oxidized disulphide form, either as homocystine or in combination with other thiol- Amino acids or peptides with a free thiol moiety, including cysteine and glutathione, are able to gen erate reactive oxygen species through an auto-oxida tion process [31] , Thiol auto-oxidation is likely to occur in the presence of trace amounts of Fe3f or Cu24, resulting in a Fenton-type reaction, with ensuing radical production [17] . Despite this, thiol compounds are not known to cause vascular damage in vivo. Compounds with a free thiol func tion, such as N-acetylcysteine and other glutathione precursors, are even thought to increase glutathione concentrations, thereby providing increased avail ability of the substrate for the intracellular enzyme glutathione peroxidase, which detoxifies hydrogen peroxide and lipid peroxides [32] , Clearly, thiol func tions have ambivalent characteristics with regard to scavenging and generation of reactive oxygen species, as we have recently shown for N-acetyleysteine [33] .
The absence of a correlation between plasma homocysteine concentration and indices o f lipid per oxidation suggests that other pathobiochemical mechanisms are responsible for the association between hyperhomocysteinaemia and atherosclero sis. The enhanced binding o f lipoprotein(a) to fibrin, induced by sulphydryl compounds, including homo cysteine, might be an alternative explanation linking thrombosis and atherosclerosis with hyperhomo cysteinaemia [34] . Also intriguing are the recently described effects of homocysteine on the endotheliumderived relaxing factor nitric oxide [35] , and the relationship between homocysteine and disturbance of fibrinolysis [36] .
In conclusion, although several parameters of lipid peroxidation, both in vivo and in vitro, were measured, no evidence was obtained that the increased risk of' arteriosclerosis in hyperhomocysteinaemia can be explained by increased lipid peroxidation. It seems more likely that another mechanism, unrelated to lipid peroxidation, is involved in vascular disease due to hyperhomocysteinaemia. In a previous short communication we reported normal concentrations o f malondialdehyde and fluor escent lipid peroxidation products in serum of CSD patients [20] . The disadvantage o f using serum for measuring lipid peroxidation products has been dis cussed previously [21, 22] . In the present study, we investigated indications o f lipid peroxidation in vivo and in vitro in EDTA-plasma of hyperhomocysteinaemic CSD patients. To our knowledge, studies on the in vitro susceptibility to oxidation o f LDL from hyperhomocystenaemic patients have not been performed before.
Materials and methods
Patients
Homozygosity for CSD was suspected in the 10 patients (nine males and one female; mean age ± SD, 30*1 ± 6*8 years) on the basis of typical clinical symptoms such as arteriosclerosis, thrombosis, mental retardation, marfanoid features or ectopia lentis, and was confirmed biochemically by severe hyperhomocysteinaemia and (in most cases) elevated methionine and decreased cysteine concentrations in plasma, and by very low cystathionine synthase activity (<10% o f that in controls) in cultured fibro blasts. At the time o f the present investigation, all patients but one (K61) were on therapy, which included pyridoxine (750 mg daily, administered orally) and in some cases folate (5 mg daily, adminis tered orally), betaine (5 g daily, administered orally) or vitamin B I2 (1 mg per month, administered intra muscularly) ( Table 1) . D ue to therapy, two patients (E51 and U58) achieved normal homocysteine levels. N o other vitamins and no antioxidants were pre scribed, and the patients had a normal diet. A control group o f 10 healthy subjects (eight males and two females) of mean age (± SD) 34*9 ± 6*0 years was selected for this study. None of the controls used any vitamins or medication. Antecubital venous blood samples were collected in the fasting state in EDTA-containing vials.
Amino acid analysis
LDL isolation and in vitro oxidation
Plasma was separated within 30 min and stored at ~80°C in the presence of 6 g saccharose L {. Lowdensity lipoproteins were isolated by a short-run ultracentrifugation method and were thereafter tested for their susceptibility to in vitro copperinduced LDL oxidation [24] . Briefly, after isolation, the LDL was dialysed for 24 h in the dark at 4°C against phosphate-buffered saline (pH 7-4), contain ing 10 /¿mol L r1 EDTA. The buffer was made oxygenfree by vacuum degassing followed by purging with nitrogen. The LDL-containing sample was filtered through a 0*45 ¿im filter and diluted with dialysis buffer to a final concentration of 0*05 mg LDLprotein mL" 1 and 10/¿mol L 1 EDTA. The oxida tion was initiated by the addition of a freshly prepared solution (15//mol L" 1) of copper chloride (C11CI2). The kinetics of LDL oxidation were determined by monitoring the change in 234 nm diene absorption on a UV-spectrophotometer (Lambda 5, Perkin-Elmer, Norwalk, CT, USA), equipped with a six-position automatic sample changer, at 30°C The change of absorbance at 234 nm vs. time was divided into three consecutive phases, i.e. a lag phase, a propagation phase and a decomposition phase (Fig. 1) . Lag time, maximal rate o f oxidation, total amount of conju gated dienes formed, and the time needed to reach maximal diene production were calculated as described previously [24] , and despite a small increase in the free CuCl2 concentration, identical kinetics of LDL oxida tion were observed [24] ,
In vivo lipid peroxidation
Other methods
The vitamin E concentrations in LDL were deter mined by high performance liquid chromatography (HPLC) as described previously [27] . LDL fatty acid composition was measured as described previously [27] , and was expressed as a percentage of total fatty n /i 
Statistical analysis
Results
Susceptibility to oxidation o f low-density lipoprotein and L D L vitamin E content
The susceptibility to oxidation o f LDL from hyperhomocysteinaemic patients was determined in vitro by continuously measuring the conjugated diene produc tion induced by incubation with copper (Fig. 1) . Oxidation resistance (expressed as lag time), maximal oxidation rate, and extent o f oxidation (expressed as total diene production) o f LD L from CSD patients were not significantly difFerent from control values ( Table 2 ). In addition, the time taken to reach max imal diene production, t(max), was similar for LDL from patients and controls. N o correlations were observed between plasma homocysteine concentra tions and biochemical LDL oxidizability indexes.
Plasma homocysteine and methionine
The homozygous CSD patients exhibited a wide range Amino acids or peptides with a free thiol moiety, including cysteine and glutathione, are able to gen erate reactive oxygen species through an auto-oxida tion process [31] , Thiol auto-oxidation is likely to occur in the presence of trace amounts of Fe3f or Cu24, resulting in a Fenton-type reaction, with ensuing radical production [17] . Despite this, thiol compounds are not known to cause vascular damage in vivo. Compounds with a free thiol func tion, such as N-acetylcysteine and other glutathione precursors, are even thought to increase glutathione concentrations, thereby providing increased avail ability of the substrate for the intracellular enzyme glutathione peroxidase, which detoxifies hydrogen peroxide and lipid peroxides [32] , Clearly, thiol func tions have ambivalent characteristics with regard to scavenging and generation of reactive oxygen species, as we have recently shown for N-acetyleysteine [33] .
Lipid peroxidation
In conclusion, although several parameters of lipid peroxidation, both in vivo and in vitro, were measured, no evidence was obtained that the increased risk of' arteriosclerosis in hyperhomocysteinaemia can be explained by increased lipid peroxidation. It seems more likely that another mechanism, unrelated to lipid peroxidation, is involved in vascular disease due to hyperhomocysteinaemia.
